Dr. Nooline Sinha

MBBS, DRM (Diagnostic Radiology & Nuclear Medicine), DNB (Nuclear Medicine)

Head – Department of Nuclear Medicine

23+ Years of Experience
Gurgaon

Dr. Nooline Sinha is an exceptionally brilliant, globally renowned senior authority in Nuclear Medicine and Molecular Theranostics. Holding a premier super-specialty DNB in Nuclear Medicine, Dr. Sinha represents the peak tier of ultra-precision diagnostic mapping and targeted radionuclide therapies in South Asia. She is universally celebrated for her expertise in interpreting complex whole-body PET-CT scans, myocardial perfusion imaging, and managing neuroendocrine tumors using advanced radionuclide therapies. Her clinical philosophy focuses on utilizing molecular imaging to detect disease metabolic signatures long before structural alterations appear on standard scans.

  • Oncological PET-CT & Molecular Imaging: High-accuracy interpretation of FDG, Ga-68 DOTANOC, and PSMA PET-CT scans for staging and evaluation of cancer treatment responses.
  • Targeted Radionuclide Therapy (Theranostics): Administering advanced Lu-177 DOTATATE therapies for neuroendocrine tumors and Lu-177 PSMA therapies for metastatic prostate cancer.
  • Radionuclide Thyroid Therapy: High-dose Iodine-131 treatments for differentiated thyroid carcinoma and hyperthyroidism.
  • Nuclear Cardiology & Renal Scans: Precise execution of myocardial perfusion imaging (MPI) and DTPA/DMSA scans to evaluate organ function.
  • Successfully interpreted over 20,000 PET-CT and molecular imaging studies, establishing an outstanding accuracy profile.
  • Instrumental in setting up advanced, high-safety radionuclide therapeutic isolation wards and hot labs at Artemis according to AERB guidelines.
  • Published valuable research inside indexed national nuclear medicine literature focusing on novel tracers for neuroendocrine tumor mapping.
  • Conferred with multiple prestigious clinical excellence tokens and leadership honors by national nuclear medicine assemblies.
  • Active life fellow of the Society of Nuclear Medicine, India (SNMI) and the World Association of Radiopharmaceutical and Molecular Therapy (WARMTH).